NCT05442645View on ClinicalTrials.gov

A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

June 27, 2023

Study Completion Date

June 18, 2024

Conditions
Atopic Dermatitis
Trial Locations (1)

Unknown

Investigational site-National Taiwan University Hospital, Taipei

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05442645 - A Study in Male and Female Adult Patients With Atopic Dermatitis Treated With Dupilumab in Taiwan | Biotech Hunter | Biotech Hunter